Vanguard Group Inc Journey Medical Corp Transaction History

Vanguard Group Inc

$6.44 Trillion
Q3 2025

A detailed history of Vanguard Group Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Vanguard Group Inc holds 615,229 shares of DERM stock, worth $4.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

615,229

Previous 564,988 8.89%

Holding current value

$4.88 Million

Previous $4.06 Million 7.37%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$6.9 - $8.54 $346,662 - $429,058	50,241 Added 8.89%	615,229 $4.36 Million
Q2 2025 Aug 11, 2025	BUY	$5.97 - $8.07 $1.15 Million - $1.56 Million	192,727 Added 51.77%	564,988 $4.06 Million
Q1 2025 May 09, 2025	BUY	$3.66 - $6.54 $172,349 - $307,968	47,090 Added 14.48%	372,261 $2.2 Million
Q3 2024 Nov 13, 2024	BUY	$4.22 - $5.91 $62,975 - $88,194	14,923 Added 4.81%	325,171 $1.84 Million
Q1 2024 May 10, 2024	BUY	$2.92 - $5.47 $527,936 - $988,976	180,800 Added 139.67%	310,248 $1.14 Million
Q4 2023 Feb 14, 2024	BUY	$2.7 - $7.96 $153,308 - $451,976	56,781 Added 78.14%	129,448 $745,000
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.97 $85,712 - $153,352	51,634 Added 245.49%	72,667 $199,000
Q2 2023 Aug 14, 2023	BUY	$1.03 - $2.26 $1 - $2	1 Added 0.0%	21,033 $33,000
Q1 2023 May 15, 2023	BUY	$1.28 - $2.54 $5,226 - $10,370	4,083 Added 24.09%	21,032 $33,000
Q4 2022 Feb 10, 2023	BUY	$1.14 - $2.85 $120 - $302	106 Added 0.63%	16,949 $32,000
Q3 2022 Nov 14, 2022	BUY	$2.46 - $4.15 $15,763 - $26,593	6,408 Added 61.41%	16,843 $41,000
Q2 2022 Aug 12, 2022	BUY	$2.62 - $5.06 $27,339 - $52,801	10,435 New	10,435 $39,000

Others Institutions Holding DERM

# of Institutions

Shares Held

8.98M

Call Options Held

Put Options Held

View Full List

About Journey Medical Corp

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $92.1M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

More about DERM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Journey Medical Corp Transaction History